Drugs / ESR-114
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03630939 | Aug 2018 → Jun 2019 | psoriasis | Escalier Biosciences B.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ESR-114 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03630939 ↗ |
| Route | Topical | “topically applied ESR-114” NCT03630939 ↗ |